Published in Medical Letter on the CDC and FDA, July 28th, 1997
The study subjects will be pregnant HIV positive women and the control group will be made up of pregnant uninfected women. The study will be conducted in Thailand and in the Ivory Coast (Cote d'Ivoire), Africa.
The Centers for Disease Control is one sponsor of the study. It recently addressed the issue, explaining its position in a question-and-answer format ("Questions and Answers: CDC Studies of AZT to Prevent Mother-to-Child HIV Transmission in Developing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.